US National Institutes of Health Director Francis Collins is appropriately cautious in setting expectations for a new public-private partnership intended to streamline development of potential COVID-19 therapeutics and vaccines.
“Will we be at the point by July or August that we have demonstrated 1 or 2 or 3 therapeutics...






